Searched for
PAUL HUDSON CEO
Sanofi buys US biopharma group Blueprint in $9.1 billion dealSanofi is set to acquire Blueprint Medicines for $9.1 billion, strengthening its immunology portfolio with the addition of Ayvakit/Ayvakyt,...- Rolls-Royce was struggling to survive, then CEO laid off 2,500 managers—now stock price has surged 500%Rolls-Royce CEO Tufan Erginbilgiç fired 2,500 employees, mainly managers, to turn the company around. This move led to a 500% share price i...
- Airline pilots, crews voice concerns about Middle East routesEuropean pilots and crew voice growing safety concerns regarding flights over the Middle East amid escalating tensions between Iran and Isr...
- Trump's newest economic sherpas are not like his old onesDuring Donald Trump's second presidential campaign, his advisory team shifted from traditional economic voices to a more unorthodox group o...
- How a rare $14 billion Japanese takeover deal got caught in US politicsTakahiro Mori of Nippon Steel Corp. traveled to Pittsburgh for a $14 billion steel merger with US Steel. Despite promises of investment and...
- Flipkart eyes quick-commerce entry; No point Googling ‘swadeshi’Flipkart has been working to cut down the timeline of its deliveries across categories for some time now. The firm rolled out same-day deli...
- France's Sanofi to buy US drugs project INBRX-101 for about $2.2 billionFrench healthcare company Sanofi has agreed to buy drug development project INBRX-101 from parent company Inhibrx Inc for $2.2 billion. INB...
- What is 'skiplagging' or 'hidden-city travel' and why is it so contentious?Though it is not illegal, the practice is strictly prohibited by airlines in their contracts of carriage. And carriers have shown an errati...
- French drugmaker Sanofi looks to spin off its consumer business in IndiaThe leading vaccine maker is working with Bank of America on the demerger process, said the people cited above. About 60% of Sanofi India i...
- France's Sanofi to manufacture vaccines developed by rival Pfizer-BioNTechThe Germany-based BioNTech will initially produce the vaccines at Sanofi facilities in Frankfurt, starting in the summer, according to a Sa...
- Sanofi and GSK launch trial for COVID-19 protein-based vaccineSanofi and GSK said in a joint statement on Thursday they had started the "Phase 1/2" trial for their adjuvanted COVID-19 vaccine, which th...
- France says any Sanofi COVID-19 vaccine for the world, no favouritesMore than 90 vaccines are currently being developed globally, with eight in the clinical trial phase. But experts say the process could tak...
- How a decade of drinking changed the future of boozeThe 2010s saw many ill advised drinking trends, ones the average bar denizen will be happy to see the back of. Still, several are poised to...
- From Brisbane’s Gabbatoir to Kolkata's Eden Gardens, the world’s most intimidating sports venuesEden’s history and partisan crowd can be daunting. At times, even for Indians players.
Load More
